Apellis Pharmaceuticals
APLS
Rank 3045
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US
Apellis Pharmaceuticals - Key figures
Market cap 4.81 Billion
Revenue 80.94 Million
Profit -253,920,000
P/E Ratio No information
P/s Ratio 59.47
Apellis Pharmaceuticals - Description
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases.
The company is headquartered in Waltham, Massachusetts.